Overexpression of the Embryonic-Lethal Abnormal Vision-like Protein HuR in Ovarian Carcinoma Is a Prognostic Factor and Is Associated with Increased Cyclooxygenase 2 Expression

Cancer Research

Volumn 64, Issue 1, 2004, Pages 189-195

  Denkert, Carsten ^a   Weichert, Wilko ^a   Pest, Sören ^b   Koch, Ines ^a   Licht, Dirk ^a   Köbel, Martin ^a   Reles, Angela ^a   Sehouli, Jalid ^a   Dietel, Manfred ^a   Hauptmann, Steffen ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; HUR PROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CARCINOMA CELL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MITOSIS RATE; OVARY CARCINOMA; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING;

ANALYSIS OF VARIANCE; ANTIGENS, SURFACE; BASE SEQUENCE; CYCLOOXYGENASE 2; CYTOPLASM; DISEASE-FREE SURVIVAL; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA-BINDING PROTEINS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 9144266290     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1987     Document Type: Article

References (23)

1. Ma, W. J., Cheng, S., Campbell, C., Wright, A., and Furneaux, H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem., 271: 8144-8151, 1996.
2. Keene, J. D. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc. Natl. Acad. Sci. USA, 96: 5-7, 1999.
3. Peng, S. S., Chen, C. Y., Xu, N., and Shyu, A. B. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J., 17: 3461-3470, 1998.
4. Fan, X. C., and Steitz, J. A. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J., 17: 3448-3460, 1998.
5. Dixon, D. A., Kaplan, C. D., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3[prime]-untranslated region. J. Biol. Chem., 275: 11750-11757, 2000.
6. O'Banion, M. K., Winn, V. D., and Young, D. A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA, 89: 4888-4892, 1992.
7. Dixon, D. A., Tolley, N. D., King, P. H., Nabors, L. B., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Investig., 108: 1657-1665, 2001.
8. Sengupta, S., Jang, B. C., Wu, M. T., Paik, J. H., Furneaux, H., and Hla, T. The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J. Biol. Chem., 278: 25227-25233, 2003.
9. Subbaramaiah, K., Marmao, T. P., Dixon, D. A., and Dannenberg, A. J. Regulation of cyclooxygenase-2 mRNA stability by taxanes. Evidence for involvement of p38, MAPKAPK-2 and HuR. J. Biol. Chem., 278: 37637-37647, 2003.
10. Cok, S. J., Acton, S. J., and Morrison, A. R. The proximal region of the 3[prime]-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1. TIAR and the heterogeneous nuclear ribonucleoprotein U. J. Biol. Chem. 278: 36157-36162, 2003.
11. Denkert, C., Kobel, M., Pest, S., Koch, I., Berger, S., Schwabe, M., Siegert, A., Reles, A., Klosterhalfen, B., and Hauptmann, S. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am. J. Pathol., 160: 893-903, 2002.
12. Hamilton, T. C., Young, R. C., McKoy, W. M., Grotzinger, K. R., Green, J. A., Chu, E. W., Whang-Peng, J., Rogan, A. M., Green, W. R., and Ozols, R. F. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res., 43: 5379-5389, 1983.
13. Fogh, J. Human Tumor Cells in Vitro. pp. 115-159. New York: Plenum Press, 1975.
14. Lau, D. H., Lewis, A. D., Ehsan, M. N., and Sikic, B. I. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Cancer Res., 51: 5181-5187, 1991.
15. Wilson, A. P. Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary. J. Natl. Cancer Inst. (Bethesda), 72: 513-521, 1984.
16. Manley, G. T., Smitt, P. S., Dalmau, J., and Posner, J. B. Hu antigens: reactivity with Hu antibodies, tumor expression and major immunogenic sites. Ann. Neurol., 38: 102-110, 1995.
17. Tora, M., Barbera, V. M., and Real, F. X. Detection of HuD transcripts by means of reverse transcriptase and polymerase chain reaction: implication for the detection of minimal residual disease in patients with small cell lung cancer. Cancer Lett., 161: 157-164, 2000.
18. Shimizu, Y., Kamoi, S., Amada, S., Hasumi, K., Akiyama, F., and Silverberg, S. G. Toward the development of a universal grading system for ovarian epithelial carcinoma. Gynecol. Oncol., 70: 2-12, 1998.
19. Atasoy, U., Watson, J., Patel, D., and Keene, J. D. ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J. Cell Sci., 111: 3145-3156, 1998.
20. Nabors, L. B., Gillespie, G. Y., Harkins, L., and King, P. H. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3[prime] untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res., 61: 2154-2161, 2001.
21. Blaxall, B. C., Dwyer-Nield, L. D., Bauer, A. K., Bohlmeyer, T. J., Malkinson, A. M., and Port, J. D. Differential expression and localization of the mRNA binding proteins. AU-rich element mRNA binding protein (AUFI) and Hu antigen R (HuR), in neoplastic lung tissue. Mol. Carcinog., 28: 76-83, 2000.
22. Wein, G., Rossler, M., Klug, R., and Herget, T. The 3[prime]-UTR of the mRNA coding for the major protein kinase C substrate MARCKS contains a novel CU-rich element interacting with the mRNA stabilizing factors HuD and HuR. Eur. J. Biochem., 270: 350-365, 2003.
23. Sheflin, L. G., Zhang, W., and Spaulding, S. W. Androgen regulates the level and subcellular distribution of the AU-rich ribonucleic acid-binding protein HuR both in vitro and in vivo. Endocrinology, 142: 2361-2368, 2001.